Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index; 97 of the 167 sources its claims cite were checked for support.

Can epigenetics shine a light on the biological pathways underlying major mental disorders?

Open access
Alameda, Luis, Trotta, Giulia, Quigley, Harriet, Rodriguez, Victoria, Gadelrab, Romayne, Dwir, Daniella, Dempster, Emma, Wong, Chloe C. Y., Forti, Marta Di · 2022 · Psychological Medicine

Abstract

A significant proportion of the global burden of disease can be attributed to mental illness. Despite important advances in identifying risk factors for mental health conditions, the biological processing underlying causal pathways to disease onset remain poorly understood. This represents a limitation to implement effective prevention and the development of novel pharmacological treatments. Epigenetic mechanisms have emerged as mediators of environmental and genetic risk factors which might play a role in disease onset, including childhood adversity (CA) and cannabis use (CU). Particularly, human research exploring DNA methylation has provided new and promising insights into the role of biological pathways implicated in the aetio-pathogenesis of psychiatric conditions, including: monoaminergic (Serotonin and Dopamine), GABAergic, glutamatergic, neurogenesis, inflammatory and immune response and oxidative stress. While these epigenetic changes have been often studied as disease-specific, similarly to the investigation of environmental risk factors, they are often transdiagnostic. Therefore, we aim to review the existing literature on DNA methylation from human studies of psychiatric diseases (i) to identify epigenetic modifications mapping onto biological pathways either transdiagnostically or specifically related to psychiatric diseases such as Eating Disorders, Post-traumatic Stress Disorder, Bipolar and Psychotic Disorder, Depression, Autism Spectrum Disorder and Anxiety Disorder, and (ii) to investigate a convergence between some of these epigenetic modifications and the exposure to known risk factors for psychiatric disorders such as CA and CU, as well as to other epigenetic confounders in psychiatry research.

Overview

CoChat Summary

TL;DR

This narrative review synthesizes human DNA methylation evidence across major psychiatric disorders and argues that several epigenetic signatures map onto transdiagnostic biological pathways, while others are more disorder-specific. It further proposes that childhood adversity and cannabis use may converge on some of these pathways, but causal mediation remains largely untested.

Key findings

  • DNA methylation changes in serotoninergic, inflammatory/immune, and neurogenesis/synaptic plasticity pathways appear transdiagnostic; dopaminergic changes are linked mainly to schizophrenia/psychosis, and glutamatergic/GABAergic changes are shared between schizophrenia and autism spectrum disorder. The review notes twin concordance estimates of 41–65% for schizophrenia, ~60% for bipolar disorder, and ~40% for major depression, and that EWAS platforms have moved from ~12,000 CpG sites to >850,000 sites.
  • Childhood adversity is associated with DNA methylation changes in HPA-axis genes: NR3C1 methylation is positively correlated with childhood adversity in borderline personality disorder and major depression but negatively correlated with anxiety and PTSD; lower FKBP5 methylation is associated with childhood adversity in psychosis and PTSD; SKA2 interacts with adversity scores in predicting lifetime suicide attempt and mediates associations with reduced cortical thickness and PTSD.
  • Cannabis use shows preliminary DNA methylation associations: the largest case–control study reported an epigenome-wide significant differentially methylated CpG in CEMIP; other studies report MARC2, CUX1, CLMN, and SENP7, with cannabis-plus-tobacco analyses identifying AHRR and F2RL3.
  • Tobacco, alcohol, and psychiatric medication are important confounders: smoking-associated genes include AHRR, F2RL3, GFI1, and MYO1G; lithium, carbamazepine, and quetiapine are associated with decreased SLC6A4 methylation, contrasting with SLC6A4 hypermethylation reported in bipolar disorder. The review also cites 115 differentially methylated regions in a depression EWAS and 39 DMRs in a monozygotic discordant twin study of major depression.

Methods

  • Design: narrative review of existing human DNA methylation studies in psychiatry, covering candidate-gene and epigenome-wide association studies (EWAS), with a focus on transdiagnostic and disorder-specific biological pathways.
  • Data: studies of eating disorders, PTSD, bipolar disorder, psychotic disorder, depression, autism spectrum disorder, and anxiety disorders, using tissues including blood, saliva, and post-mortem brain; childhood adversity and cannabis use are reviewed as environmental exposures, with supplementary tables summarizing study characteristics.
  • Analysis: narrative synthesis with tables and figures summarizing direction of associations and mediation analyses; no new primary data or formal meta-analysis are reported.

Limitations

  • The paper states technical limitations including blood–brain inconsistencies, tissue-type specificity, and the candidate-gene versus EWAS issue; it also notes that most included studies are small and underpowered, except some exceptions such as Hannon et al. (2021).
  • The paper states that EWAS-level evidence formally testing mediating pathways between childhood adversity and main clinical conditions is non-existent in humans, and that studies often use broad composite adversity measures, heterogeneous diagnostic categories, and lack information on timing of trauma or cannabis initiation.
  • The paper states that genotype, gene expression, and environmental confounders such as tobacco, alcohol, and psychiatric medication are often unaccounted for; evident from the text, as a narrative review it does not describe a systematic search strategy or formal quality appraisal.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1017/s0033291721005559

Cites

186 of 186 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1. Summary of the evidence on potential pathways linking childhood trauma and cannabis use with psychiatric conditions through DNAm changes. Note: This figure summarises the evidence presented in this review, highlighting the idea that some biological pathways linking environmental risk factors with mental health disorders via epigenetic changed in the form of DNAm are transdiagnostics (e.g immune system/inflammation) while others seem to be more specific (e.g dopaminergic system). (1) The environmental risk factors row and epigenetic modifications row suggest links between childhood adversity (CA), and Cannabis use (CU) and DNAm changes mapping to biological pathways which are also functionally related (Serotoninergic, Dopaminergic pathways, Glutamatergic & GABAergic pathway, Neurogenesis, Immune system & Inflammation and Oxidative stress). (2)The epigenetic modifications row and mental health disorders row illustrate the evidence, from case–control studies, of an association between DNAm changes in these pathways and the major mental health conditions (Eating Disorders (anorexia nervosa and bulimia nervosa) Post-traumatic stress disorder, Anxiety Disorders, Psychotic Disorder, Bipolar disorders, Depression and Autism Spectrum Disorders). (3) The arrows connecting the three rows show the potential mediating role of DNAm changes linking CA and CU and risk to develop mental health conditions. The thickness of the lines shows the robustness of the evidence reported in the literature review. The items “genotype: and “other risk factors” are added to highlight the influence of genetic factors and environmental confounders in DNAm studies. The dotted line connecting eating disorders with the pathways indicate that literature was limited and mixed not allowing to draw clear links with the pathways.
Fig. 1. Summary of the evidence on potential pathways linking childhood trauma and cannabis use with psychiatric conditions through DNAm changes. Note: This figure summarises the evidence presented in this review, highlighting the idea that some biological pathways linking environmental risk factors with mental health disorders via epigenetic changed in the form of DNAm are transdiagnostics (e.g immune system/inflammation) while others seem to be more specific (e.g dopaminergic system). (1) The environmental risk factors row and epigenetic modifications row suggest links between childhood adversity (CA), and Cannabis use (CU) and DNAm changes mapping to biological pathways which are also functionally related (Serotoninergic, Dopaminergic pathways, Glutamatergic & GABAergic pathway, Neurogenesis, Immune system & Inflammation and Oxidative stress). (2)The epigenetic modifications row and mental health disorders row illustrate the evidence, from case–control studies, of an association between DNAm changes in these pathways and the major mental health conditions (Eating Disorders (anorexia nervosa and bulimia nervosa) Post-traumatic stress disorder, Anxiety Disorders, Psychotic Disorder, Bipolar disorders, Depression and Autism Spectrum Disorders). (3) The arrows connecting the three rows show the potential mediating role of DNAm changes linking CA and CU and risk to develop mental health conditions. The thickness of the lines shows the robustness of the evidence reported in the literature review. The items “genotype: and “other risk factors” are added to highlight the influence of genetic factors and environmental confounders in DNAm studies. The dotted line connecting eating disorders with the pathways indicate that literature was limited and mixed not allowing to draw clear links with the pathways.CC BY · PubMed Central
Fig. 2. Summary of the evidence linking childhood adversity and DNAm changes on the Hipotalamic Pituitary Adrenal Axis in various conditions as well as with some clinical measures. Note: This Figure illustrates the evidence from candidate gene studies linking childhood adversity (CA) with DNAm in CpG sites located in NR3C1, FKBP5, SKA2 and CA, with various conditions and various clinical outcomes. In the gene and DNAm columns, CA + (with an arrow pointing up) reflects the presence of a positive association between the DNAm in probes located in those genes and CA; CA- (with an arrow pointing down) reflects a negative association. The disorder column shows in which mental health condition that association has been found. Lastly, the clinical outcomes column shows the presence of evidence linking DNAm, with a particular clinical phenotype; CA + indicated that the association between DNAm and the clinical outcome was related to CA.
Fig. 2. Summary of the evidence linking childhood adversity and DNAm changes on the Hipotalamic Pituitary Adrenal Axis in various conditions as well as with some clinical measures. Note: This Figure illustrates the evidence from candidate gene studies linking childhood adversity (CA) with DNAm in CpG sites located in NR3C1, FKBP5, SKA2 and CA, with various conditions and various clinical outcomes. In the gene and DNAm columns, CA + (with an arrow pointing up) reflects the presence of a positive association between the DNAm in probes located in those genes and CA; CA- (with an arrow pointing down) reflects a negative association. The disorder column shows in which mental health condition that association has been found. Lastly, the clinical outcomes column shows the presence of evidence linking DNAm, with a particular clinical phenotype; CA + indicated that the association between DNAm and the clinical outcome was related to CA.CC BY · PubMed Central

Verification

Claims the paper makes

62 Valid · 7 Not valid · 25 Not checked · 31 Own results and interpretations

67 more claims · 30 with their cited sources checked

Create a free account to see all 125 claims and to verify the 13 references still open.

See all claims — free account
  • It may state two separate claims as one. 50
  • The quote only partly states this claim. 1
  • Probably not a substantial claim. 4

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 7 · the rest aren’t loaded

2 more findings

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 183 references

Research works printed but not linked: 2

  1. Thaler, 2017, Advances in Experimental Medicine and Biology, 978, 93
  2. Wong, C. , Smith, R. , Hannon, E. , Ramaswami, G. , Parikshak, N. , Assary, E. , … Sun, W. (2018). Genome-wide DNA methylation profiling identifies convergent molecular signatures associated with idiopathic and syndromic forms of autism in postmortem human brain tissue. 28(13), 394387. · DOI · Paper page

Cited by

See all 60

Metadata

Authors
Alameda, L., Trotta, G., Quigley, H., Rodriguez, V., Gadelrab, R., Dwir, D., Dempster, E., Wong, C. C. Y., & Forti, M. D.
Affiliations
  • King's College London (GB)
  • Centre Hospitalier Universitaire Vaudois (CH)
  • University of Exeter (GB)
Corresponding author
Forti, Marta Di
Venue
Psychological Medicine
Published
2022-02-23
Volume
52
Issue
9
Pages
1645-1665
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
OpenAlex
W4213452157
Cited by
60
References
183
Citations by year
2026: 9 · 2025: 19 · 2024: 17 · 2023: 8 · 2022: 7
FWCI
1.33
Type
journal article
Language
en
Open access
Locations
  • Psychological Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion, cc-by)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
  • IRIS (submittedVersion, cc-by)
  • RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
  • Research Portal (King's College London) (submittedVersion, cc-by)
Funders
swiss national foundation (P2LAP3_171804)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Social Sciences › Psychology › Clinical Psychology › Child Abuse and Trauma
Keywords
epigenetics, DNA methylation, mental illness, childhood adversity, cannabis use, monoaminergic systems, GABAergic system, glutamatergic system, neurogenesis, neuroinflammation, oxidative stress, eating disorders, post-traumatic stress disorder, bipolar disorder, psychosis, depression, autism spectrum disorder, anxiety disorders, psychiatric risk factors
MeSH terms
Autism Spectrum Disorder, Mental Disorders, Humans, Psychotic Disorders, Stress Disorders, Post-Traumatic, DNA Methylation, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Can epigenetics shine a light on the biological pathways underlying major mental disorders? https://app.cochat.ai/papers/10.1017/s0033291721005559
The paper
Alameda, L., Trotta, G., Quigley, H., Rodriguez, V., Gadelrab, R., Dwir, D., Dempster, E., Wong, C. C. Y., & Forti, M. D. (2022). Can epigenetics shine a light on the biological pathways underlying major mental disorders? Psychological Medicine. https://doi.org/10.1017/s0033291721005559

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.